Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Rand...
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial
About this item
Full title
Author / Creator
Boyer, David S. , Gonzalez, Victor H. , Kunimoto, Derek Y. , Maturi, Raj K. , Roe, Richard H. , Singer, Michael A. , Xavier, Samantha , Kornfield, Julie A. , Kuppermann, Baruch D. , Quiroz-Mercado, Hugo , Aubel, Janine , Karageozian, Hampar L. , Park, John Y. , Karageozian, Vicken H. , Karageozian, Lisa , Sarayba, Melvin A. and Kaiser, Peter K.
Publisher
Thorofare: Slack, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Thorofare: Slack, Inc
Subjects
More information
Scope and Contents
Contents
BACKGROUND AND OBJECTIVE: To evaluate the safety and efficacy of 1.0 mg risuteganib in subjects with nonexudative age-related macular degeneration (AMD). PATIENTS AND METHODS: This was a phase 2a, prospective, double-masked, sham-controlled study. Eyes with nonexudative (dry) AMD and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected...
Alternative Titles
Full title
Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial
Authors, Artists and Contributors
Author / Creator
Gonzalez, Victor H.
Kunimoto, Derek Y.
Maturi, Raj K.
Roe, Richard H.
Singer, Michael A.
Xavier, Samantha
Kornfield, Julie A.
Kuppermann, Baruch D.
Quiroz-Mercado, Hugo
Aubel, Janine
Karageozian, Hampar L.
Park, John Y.
Karageozian, Vicken H.
Karageozian, Lisa
Sarayba, Melvin A.
Kaiser, Peter K.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2546975613
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2546975613
Other Identifiers
ISSN
2325-8160
E-ISSN
2325-8179
DOI
10.3928/23258160-20210528-05
